Noradrenalina Basi (Noradrenaline Tartrate)

Norepinephrine, the active ingredient in Noradrenalina Basi, is a vasopressor presented as an injectable solution for intravenous use. It is employed to raise blood pressure in patients experiencing severe hypotension, such as those in septic or cardiogenic shock, by stimulating adrenergic receptors.

GNH USA supplies Noradrenalina Basi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, intensive care units and transplant centres worldwide. Our product meets EU quality standards and our supply chain ensures consistent availability and regulatory compliance for critical care settings.

Noradrenaline is used as a potent vasopressor in acute circulatory failure and shock states.

- Septic shock: restores vascular tone and improves mean arterial pressure in patients with sepsis‑induced hypotension. - Cardiogenic shock: supports cardiac output by increasing systemic vascular resistance in heart‑failure‑related shock. - Acute hypotension: rapidly elevates blood pressure during anesthesia or severe blood loss.

Administration of norepinephrine may be associated with several adverse reactions, ranging from frequent to rare but serious.

Common Side Effects: - Headache: mild to moderate intensity. - Tachycardia: increased heart rate. - Arrhythmia: irregular heart rhythm. - Peripheral ischemia: reduced blood flow to extremities. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypertension: dangerously high blood pressure. - Cardiac ischemia: reduced blood supply to heart muscle. - Tissue necrosis: local tissue death at infusion site. - Pulmonary edema: fluid accumulation in lungs.

Careful monitoring and specific precautions are required when using norepinephrine intravenously. - Blood pressure monitoring: continuously assess arterial pressure to avoid overshoot. - Cardiac function assessment: evaluate heart rate and rhythm before and during infusion. - Peripheral perfusion checks: inspect infusion sites for signs of ischemia. - Dosage titration: adjust infusion rate gradually based on response. - Contraindications review: avoid use in patients with uncorrected pheochromocytoma or hypersensitivity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine can interact with other agents, influencing its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: may cause excessive hypertensive response. - Tricyclic antidepressants: potentiate vasoconstrictive effects. - Beta‑blockers: may blunt desired increase in cardiac output.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may require higher norepinephrine doses. - Calcium channel blockers: can affect vascular tone. - Diuretics: may influence intravascular volume and response.